{"url_path":"/sec/anro/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1999480/0001999480-26-000012-index.html","accession_number":"0001999480-26-000012","cik":"0001999480","ticker":"ANRO","issuer_name":"Alto Neuroscience, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1999480/0001999480-26-000012-index.html","primary_entity_key":"0001999480","primary_entity_name":"Alto Neuroscience, Inc."},"word_count":288,"has_tables":true,"body_markdown":"Item 6. Exhibits.\n\nExhibit No.DescriptionFormFile No.ExhibitFiling DateFiled Herewith\n\n3.1\n[Amended and Restated Certificate of Incorporation of the Registrant](https://www.sec.gov/Archives/edgar/data/1999480/000119312524025266/d736911dex31.htm)\n8-K001-419443.12/6/2024\n\n3.2\n[Amended and Restated Bylaws of the Registrant](https://www.sec.gov/Archives/edgar/data/1999480/000119312524025266/d736911dex32.htm)\n8-K001-419443.22/6/2024\n\n4.1\n[Form of Pre-Funded Warrant](https://www.sec.gov/Archives/edgar/data/1999480/000110465925100801/tm2529007d1_ex4-1.htm)\n8-K001-419444.110/20/2025\n\n4.2\n[Form of Pre-Funded Warrant](https://www.sec.gov/Archives/edgar/data/1999480/000110465926027953/tm268876d1_ex4-1.htm)\n8-K001-419444.13/16/2026\n\n31.1\n[Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](exhibit311-302certceo1q2026.htm)\nX\n\n31.2\n[Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](exhibit312-302certcfo1q2026.htm)\nX\n\n32.1*\n[Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](exhibit321-906certceo1q2026.htm)\nX\n\n32.2*\n[Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](exhibit322-906certcfo1q2026.htm)\nX\n\n101.INSInline XBRL Instance Document.X\n\n101.SCHTaxonomy Extension Schema With Embedded Linkbase DocumentsX\n\n104Cover Page Interactive Data File (formatted in iXBRL and contained in Exhibit 101).X\n\n*    This certification is deemed not filed for purposes of Section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.\n\n39\n\n[Table of Contents](#if33b9e8d46eb467b84758fa9b250d8f7_7)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\nALTO NEUROSCIENCE, INC.\n\nDate:May 13, 2026By:/s/ Amit Etkin\n\nAmit Etkin, M.D., Ph.D.\n\nPresident and Chief Executive Officer\n\nDate:May 13, 2026By:/s/ Nicholas Smith\n\nNicholas Smith\n\nChief Financial Officer and Chief Business Officer\n\n40"}